Hugues Sicotte

ORCID: 0000-0002-0304-8515
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic and Hepatic Oncology Research
  • Chromatin Remodeling and Cancer
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Prostate Cancer Treatment and Research
  • Mechanisms of cancer metastasis
  • Cancer Genomics and Diagnostics
  • Cancer, Lipids, and Metabolism
  • Estrogen and related hormone effects
  • Glioma Diagnosis and Treatment
  • Cancer Research and Treatments
  • Ovarian cancer diagnosis and treatment
  • Molecular Biology Techniques and Applications
  • Radiopharmaceutical Chemistry and Applications
  • Genetic Associations and Epidemiology
  • Cancer-related molecular mechanisms research
  • RNA modifications and cancer
  • Liver Disease Diagnosis and Treatment
  • MicroRNA in disease regulation
  • Epigenetics and DNA Methylation
  • Cancer-related Molecular Pathways
  • Gene expression and cancer classification
  • Telomeres, Telomerase, and Senescence
  • Atherosclerosis and Cardiovascular Diseases
  • Genomics and Phylogenetic Studies
  • Bioinformatics and Genomic Networks

Mayo Clinic
2014-2025

WinnMed
2014-2025

Mayo Clinic in Florida
2011-2024

Mayo Clinic in Arizona
2012-2022

University of Minnesota Rochester
2017

Jacksonville College
2016

University of California, San Francisco
2013-2014

Department of Medical Sciences
2014

Babol University of Medical Sciences
2014

Charlottesville Medical Research
2014

The prediction of clinical behavior, response to therapy, and outcome infiltrative glioma is challenging. On the basis previous studies tumor biology, we defined five molecular groups with use three alterations: mutations in TERT promoter, IDH, codeletion chromosome arms 1p 19q (1p/19q codeletion). We tested hypothesis that within based on these features, tumors would have similar variables, acquired somatic alterations, germline variants.We scored as negative or positive for each markers...

10.1056/nejmoa1407279 article EN New England Journal of Medicine 2015-06-11

Although the costs of next generation sequencing technology have decreased over past years, there is still a lack simple-to-use applications, for comprehensive analysis RNA data. There no one-stop shop transcriptomic genomics. We developed MAP-RSeq, computational workflow that can be used obtaining genomic features from data, any genome. For optimization tools and parameters, MAP-RSeq was validated using both simulated real datasets. consists six major modules such as alignment reads,...

10.1186/1471-2105-15-224 article EN cc-by BMC Bioinformatics 2014-06-27

Abstract Background Stored biological samples with pathology information and medical records are invaluable resources for translational research. However, RNAs extracted from the archived clinical tissues often substantially degraded. RNA degradation distorts RNA-seq read coverage in a gene-specific manner, has profound influences on whole-genome gene expression profiling. Result We developed transcript integrity number (TIN) to measure degradation. When applied 3 independent datasets, we...

10.1186/s12859-016-0922-z article EN cc-by BMC Bioinformatics 2016-02-03

Abstract Background Glioblastoma (GBM) exhibits profound intratumoral genetic heterogeneity. Each tumor comprises multiple genetically distinct clonal populations with different therapeutic sensitivities. This has implications for targeted therapy and informed paradigms. Contrast-enhanced (CE)-MRI conventional sampling techniques have failed to resolve this heterogeneity, particularly nonenhancing populations. study explores the feasibility of using multiparametric MRI texture analysis...

10.1093/neuonc/now135 article EN Neuro-Oncology 2016-08-08

Abstract Ovarian cancer is a clinically and molecularly heterogeneous disease. The driving forces behind this variability are unknown. Here, we report wide variation in the expression of DNA cytosine deaminase APOBEC3B, with elevated majority ovarian cell lines (three SDs above mean normal surface epithelial cells) high-grade primary cancers. APOBEC3B active nucleus several elicits biochemical preference for deamination cytosines 5′-TC dinucleotides. Importantly, examination whole-genome...

10.1158/0008-5472.can-13-1753 article EN Cancer Research 2013-10-24
Kristen S. Purrington Susan Slager Diana Eccles Drakoulis Yannoukakos Peter A. Fasching and 95 more Penelope Miron Jane Carpenter Jenny Chang‐Claude Nicholas G. Martin Grant W. Montgomery Vessela Kristensen Hoda Anton‐Culver Paul J. Goodfellow William Tapper Sajjad Rafiq Susan M. Gerty Lorraine Durcan Irene Konstantopoulou Florentia Fostira Athanassios Vratimos Paraskevi Apostolou Irene Konstanta Vassiliki Kotoula Sotiris Lakis Meletios Α. Dimopoulos Dimosthenis Skarlos Dimitrios Pectasides George Fountzilas Matthias W. Beckmann Alexander Hein Matthias Ruebner Arif B. Ekici Arndt Hartmann R. Schulz-Wendtland Stefan P. Renner Wolfgang Janni Brigitte Rack Christoph Scholz Julia Neugebauer Ulrich Andergassen Michael P. Lux Lothar Haeberle Christine L. Clarke Nirmala Pathmanathan Anja Rudolph Dieter Flesch‐Janys Stefan Nickels Janet E. Olson James N. Ingle Curtis Olswold Seth W. Slettedahl Jeanette E. Eckel‐Passow S. Keith Anderson Daniel W. Visscher Victoria Cafourek Hugues Sicotte Naresh Prodduturi Elisabete Weiderpass Leslie Bernstein Argyrios Ziogas Jennifer Ivanovich Graham G. Giles Laura Baglietto Melissa C. Southey Veli-Matti Kosma H.-P. Fischer Malcolm Reed Simon S. Cross Sandra Deming-Halverson Martha J. Shrubsole Qiuyin Cai Xiao‐Ou Shu Mary B. Daly JoEllen Weaver Eric A. Ross Jennifer R. Klemp Priyanka Sharma Diana Torres Thomas Rüdiger Heidrun Wölfing Hans-Ulrich Ulmer Asta Försti Thaer Khoury Shicha Kumar Robert Pilarski Charles L. Shapiro Dario Greco Päivi Heikkilä Kristiina Aittomäki Carl Blomqvist Astrid Irwanto Jianjun Liu V. Shane Pankratz Xianshu Wang Gianluca Severi Graham J. Mann Douglas F. Easton Per Hall Hiltrud Brauch Angela Cox

Triple-negative (TN) breast cancer is an aggressive subtype of associated with a unique set epidemiologic and genetic risk factors. We conducted two-stage genome-wide association study TN (stage 1: 1529 cases, 3399 controls; stage 2: 2148 1309 controls) to identify loci that influence risk. Variants in the 19p13.1 PTHLH showed significant associations (P < 5 × 10−8) 1 2 combined. Results also suggested substantial enrichment significantly variants among single nucleotide polymorphisms (SNPs)...

10.1093/carcin/bgt404 article EN Carcinogenesis 2013-12-09

Abstract Purpose: Androgen receptor (AR) variant AR-V7 is a ligand-independent transcription factor that promotes prostate cancer resistance to AR-targeted therapies. Accordingly, efforts are under way develop strategies for monitoring and inhibiting in castration-resistant (CRPC). The purpose of this study was understand whether other AR variants may be coexpressed with promote Experimental Design: We utilized complementary short- long-read sequencing intact mRNA isoforms characterize...

10.1158/1078-0432.ccr-17-0017 article EN Clinical Cancer Research 2017-05-05
Liewei Wang Steven E. Scherer Suzette J. Bielinski Donna M. Muzny Leila A. Jones and 95 more John L. Black Ann M. Moyer Jyothsna Giri Richard R. Sharp Eric T. Matey Jessica Wright Lance J. Oyen Wayne T. Nicholson Mathieu Wiepert Terri Sullard Timothy B. Curry Carolyn R. Rohrer Vitek Tammy M. McAllister Jennifer L. St. Sauver Pedro J. Caraballo Konstantinos N. Lazaridis Eric Venner Xiang Qin Taobo Hu Christie Kovar Viktoriya Korchina Kimberly Walker HarshaVardhan Doddapaneni Tsung-Jung Wu Ritika Raj Shawn Denson Wen Liu Gauthami Chandanavelli Lan Zhang Qiaoyan Wang Divya Kalra Mary Beth Karow Kimberley Harris Hugues Sicotte Sandra E. Peterson Amy E. Barthel Brenda E. Moore Jennifer M. Skierka Michelle L. Kluge Katrina E. Kotzer Karen M. Kloke Jessica M. Vander Pol Heather Marker Joseph Sutton Adrijana Kekic Ashley Ebenhoh Dennis M. Bierle Michael J. Schuh C. Grilli Sara M. Erickson Audrey Umbreit Leah Ward Sheena Crosby Eric Nelson Sharon Levey Michelle A. Elliott Steve G. Peters Naveen L. Pereira Mark A. Frye Fadi Shamoun Matthew P. Goetz Iftikhar J. Kullo Robert A. Wermers Jan A. Anderson Christine M. Formea Razan M. El Melik John D. Zeuli Joseph R. Herges Carrie A. Krieger Robert W. Hoel Jodi L. Taraba Scott R. St. Thomas Imad Absah Matthew Bernard Stephanie Fink Andrea A. Gossard Pamela L. Grubbs Therese M. Jacobson Paul Y. Takahashi Sharon C. Zehe Susan Buckles Michelle Bumgardner Colette Gallagher Kelliann C. Fee-Schroeder Nichole R. Nicholas Melody L. Powers Ahmed K. Ragab Darcy M. Richardson Anthony Stai Jaymi Wilson Joel E. Pacyna Janet E. Olson Erica J. Sutton Annika T. Beck Caroline Horrow

10.1016/j.gim.2022.01.022 article EN publisher-specific-oa Genetics in Medicine 2022-03-21

We conducted a genome-wide association study to identify novel genes influencing diastolic blood pressure (BP) response hydrochlorothiazide, commonly prescribed thiazide diuretic preferred for the treatment of high BP. Affymetrix GeneChip Human Mapping 100K Arrays were used measure single nucleotide polymorphisms across 22 autosomes in 194 non-Hispanic black subjects and 195 white with essential hypertension selected from opposite tertiles race- sex-specific distributions age-adjusted BP...

10.1161/hypertensionaha.107.104273 article EN Hypertension 2008-07-01

Background: Breast cancer patients with residual disease after neoadjuvant chemotherapy (NAC) have increased recurrence risk. Molecular characterization, knowledge of NAC response, and simultaneous generation patient-derived xenografts (PDXs) may accelerate drug development. However, the feasibility this approach is unknown. Methods: We conducted a prospective study 140 breast treated performed tumor germline sequencing generated using core needle biopsies. Chemotherapy response was assessed...

10.1093/jnci/djw306 article EN cc-by-nc JNCI Journal of the National Cancer Institute 2016-11-24

Abstract Background Glioblastoma (GBM) represents an aggressive cancer type with a median survival of only 14 months. With fewer than 5% patients surviving 5 years, comprehensive profiling these rare could elucidate prognostic biomarkers that may confer better patient outcomes. We utilized multiple molecular approaches to characterize the largest cohort isocitrate dehydrogenase (IDH)–wildtype GBM long-term survivors (LTS) date. Methods Retrospective analysis was performed on 49 archived...

10.1093/neuonc/noz129 article EN Neuro-Oncology 2019-07-24

Background Expression level of many genes shows abundant natural variation in human populations. The variations gene expression are believed to contribute phenotypic differences. Emerging evidence has shown that microRNAs (miRNAs) one the key regulators expression. However, past studies have focused on miRNA target and used loss- or gain-of-function approach may not reflect association between mRNAs. Methodology/Principal Findings To examine regulatory effect global under endogenous...

10.1371/journal.pone.0005878 article EN cc-by PLoS ONE 2009-06-10

Genomewide association studies ( GWAS ) and candidate‐gene have implicated single‐nucleotide polymorphisms SNP s) in at least 45 different genes as putative glioma risk factors. Attempts to validate these associations yielded variable results few genetic factors been consistently replicated. We conducted a case‐control study of Caucasian cases controls from the University California San Francisco (810 cases, 512 controls) Mayo Clinic (852 789 an attempt replicate previously reported for...

10.1002/gepi.21707 article EN Genetic Epidemiology 2012-12-31

Abstract Motivation: Exome sequencing (exome-seq) data, which are typically used for calling exonic mutations, have also been utilized in detecting DNA copy number variations (CNVs). Despite the existence of several CNV detection tools, there is still a great need sensitive and an accurate CNV-calling algorithm with built-in QC steps, does not require paired reference each sample. Results: We developed novel method named PatternCNV, (i) accounts read coverage between exons while leveraging...

10.1093/bioinformatics/btu363 article EN Bioinformatics 2014-05-29

To determine early somatic changes in high-grade serous ovarian cancer (HGSOC), we performed whole genome sequencing on a rare collection of 16 low stage HGSOCs. The majority showed extensive structural alterations (one had an ultramutated profile), exhibited high levels p53 immunoreactivity, and harboured TP53 mutation, deletion or inactivation. BRCA1 BRCA2 mutations were observed two tumors, with nine showing evidence homologous recombination (HR) defect. Combined Analysis Cancer Genome...

10.1093/nar/gkv111 article EN cc-by Nucleic Acids Research 2015-04-27

Genome-wide association studies have implicated single nucleotide polymorphisms (SNPs) in 7 genes as glioma risk factors, including 2 (TERT, RTEL1) involved telomerase structure/function. We examined associations of these established loci with age at diagnosis among patients glioma. SNP genotype data were available for 2286 Caucasian from the University California, San Francisco (n = 1434) and Mayo Clinic 852). Regression analyses performed to test between "number alleles" "age diagnosis,"...

10.1093/neuonc/not051 article EN Neuro-Oncology 2013-06-03

770 Background: Pancreatic ductal adenocarcinoma (PDAC) is associated with poor prognosis and limited treatment options. A 584 bp deletion in CTRB2 , which impairs chymotrypsin B2 function, has been linked to increased PDAC risk. This study investigates the impact of this on progression survival outcomes patients PDAC. Methods: There were 633 whom CTRB2ex6 was genotyped; 263 received chemotherapy had time (TTP) information. TTP calculated from diagnosis date until earliest 1) (event), 2)...

10.1200/jco.2025.43.4_suppl.770 article EN Journal of Clinical Oncology 2025-01-27
Coming Soon ...